The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of BRAF/MEK inhibitor rechallenge in patients with advanced melanoma: Systematic review and meta-analysis.
 
Jonathan N. Priantti
No Relationships to Disclose
 
Maysa Vilbert
No Relationships to Disclose
 
Thiago Madeira
No Relationships to Disclose
 
Francisco Cezar A Moraes
No Relationships to Disclose
 
Erica C. Koch Hein
Consulting or Advisory Role - MSD; Novartis; Novartis
Speakers' Bureau - MSD; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Pfizer; Roche Pharma AG
 
Ludimila Cavalcante
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
Consulting or Advisory Role - Pliant